Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
R I Med J (2013) ; 104(4): 53-57, 2021 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-33926162

RESUMEN

OBJECTIVES: Use of anticoagulant and antiplatelet medications (AAMs) is increasing significantly with our growing population of older adults. AAMs worsen outcomes in trauma patients. Our goal was to improve collaboration between trauma and outpatient providers and to improve safety in making decisions on anticoagulant and antiplatelet medications(AAMs) after injuries. DESIGN: A risk management initiative. SETTING AND PARTICIPANTS: Patients that suffered traumatic injury while on anticoagulation or antiplatelets medications at a level I university trauma center. METHODS: IRB approval was obtained to review records for medications, demographics, mechanism and type of injury, and indication for preinjury AAM use. Inpatient trauma team providers contacted the primary prescriber. A collaborative decision was made regarding AAM plans. RESULTS: One hundred and five patients, mean age 79 years, were followed. The three most common AAMs were warfarin (69 patients), clopidogrel (24), and Factor Xa inhibitors (16). Atrial fibrillation was the most common indication for AAMs (70 patients), venous thrombosis (14) and TIA/CVA (11). Falls were the most frequent injury mechanism, 79.4%. Soft tissue hematomas (27.4%), TBI (16%), and pelvic fractures (12.3%) were the most common injuries. In 56.6% AAMs were held until follow-up, 31.1% had AAMs resumed at discharge, and AAMs were held indefinitely in 12.3%. Patients discharged to home versus facility (37 vs 18% p<0.05), <75 years of age (47 vs 27% p<0.05) were more likely to have AAMs resumed at discharge. Patients who suffered falls versus MVC mechanism were less likely to have AAMs resumed at discharge (28 vs 82% p<0.05). CHA2DS2-VASc scores were similar between decision groups. CONCLUSIONS AND IMPLICATIONS: This is the first description of mandatory communication between trauma and outpatient providers to guide decision making on AAMs after injury. Efforts should be made to determine if this mitigates risk by following patients longterm. This communication should become standard for a population that is often elderly, frail, and at risk of repeat injuries.


Asunto(s)
Anticoagulantes , Inhibidores de Agregación Plaquetaria , Anciano , Anticoagulantes/efectos adversos , Toma de Decisiones , Humanos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Estudios Retrospectivos , Rhode Island/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA